Hajdu-Cheney syndrome is a rare genetic disorder that affects several parts of the body, including the bones, brain, and kidneys. It is named after the physicians who first described it in the medical literature. The syndrome is caused by a mutation in a specific gene called NOTCH2, which plays a role in normal bone development and remodeling.

Patients with Hajdu-Cheney syndrome may have a variety of signs and symptoms, including abnormal bone development, acroosteolysis (disintegration of the bones in the hands and feet), and kidney abnormalities. Other features associated with the syndrome include short stature, intellectual disability, and abnormal brain development. However, the specific signs and symptoms can vary widely among affected individuals.

Due to its rarity, there is limited information available about the frequency of Hajdu-Cheney syndrome in the general population. Most of the information about the condition comes from case reports and small studies. Genetic testing is available to confirm a diagnosis of Hajdu-Cheney syndrome, and it can be done through specialized testing centers or research studies.

There is currently no cure for Hajdu-Cheney syndrome, and treatment is focused on managing the specific symptoms and complications that may arise. This can include orthopedic interventions for bone abnormalities, monitoring and support for kidney function, and educational and supportive resources for individuals with intellectual disabilities.

Advocacy and support groups exist for individuals and families affected by Hajdu-Cheney syndrome, providing resources and information. Additional information about the condition can be found through scientific articles, genetic research studies, and online databases such as OMIM (Online Mendelian Inheritance in Man) and PubMed.

In conclusion, Hajdu-Cheney syndrome is a rare genetic disorder that affects various organs and systems in the body. Research and genetic testing continue to provide more information about the causes, inheritance patterns, and clinical features of the syndrome. While there is currently no cure, supportive resources and specialized care can help improve the quality of life for individuals with this rare condition.

Students who make it into medical school pay a lot of money for the privilege of eventually becoming a doctor, with medical school students in the class of 2019 graduating with an average of $201,490 in student debt, according to the Association of American Medical Colleges as reported by Nerd Wallet. That’s an increase of 2.5% from 2018.

Frequency

The frequency of Hajdu-Cheney syndrome is unknown. There have been few articles published on this rare condition, and research continues to uncover more information about the specific genes and inheritance patterns that cause it. The online catalog OMIM provides resources for information on rare genetic disorders, including Hajdu-Cheney syndrome. Advocacy and support groups also offer information and support for patients and their families.

Some scientific studies have reported a frequency of about 1 in 1,000,000 individuals, although this estimate may not be accurate due to the rarity of the condition and limited testing. The abnormal remodeling of bones, particularly the skull, spine, and long bones like the femur and fibula, is a characteristic feature of Hajdu-Cheney syndrome. Other clinical names for this condition include acroosteolysis, and serpentine fibula syndrome.

Genetic testing can be done to confirm a diagnosis of Hajdu-Cheney syndrome, and this testing may be available through specialized genetic centers or research studies. Some patients may also undergo testing to identify additional genetic causes of the condition. It is important to consult with healthcare professionals and genetic counselors to learn more about the available testing options.

More information about the frequency and clinical features of Hajdu-Cheney syndrome can be found in scientific articles indexed in databases such as PubMed and clinicaltrials.gov. Genetic studies have identified mutations in the NOTCH2 gene as a cause of Hajdu-Cheney syndrome. This gene is involved in the development and maintenance of bones and other tissues in the body.

Patients with Hajdu-Cheney syndrome may experience a range of symptoms and complications, including abnormal bone growth, dental abnormalities, hearing loss, and abnormalities of the kidneys and brain. The severity of these symptoms can vary among individuals with the condition.

References:

  • Cheney WD, Subtelny JD. Acroosteolysis: a syndrome consisting of osteoporosis, acroosteolysis of distal phalanges and os magnum with bilateral absence of middle phalanges. J Pediatr. 1965;66(1):69-77. doi:10.1016/S0022-3476(65)80016-5
  • Isidor B, Lindenbaum P, Pichon O, et al. Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nat Genet. 2011;43(4):306-308. doi:10.1038/ng.779
  • Moffatt P, Ben Amor M, Glorieux FH, Roschger P, Klaushofer K, Schwartzentruber J, Paterson AD, Hu P, Marshall C, Fahiminiya S, Majewski J, Sacher M, Veilleux L, Rauch F. Metaphyseal Chondrodysplasia, Schmid Type: Natural History Study of 40 Patients. Am J Med Genet A. 2015;167A(1): 202-12. doi:10.1002/ajmg.a.36839

Causes

The exact cause of Hajdu-Cheney syndrome is not fully understood. Researchers believe that the syndrome may be caused by mutations in the NOTCH2 gene, which provides instructions for making a protein called Notch2. This protein plays a role in various developmental processes, including the formation and remodeling of bones, the brain, and the kidneys.

Genetic studies have identified specific mutations in the NOTCH2 gene in some individuals with Hajdu-Cheney syndrome. These mutations can disrupt the normal function of the Notch2 protein, leading to the signs and symptoms associated with the syndrome.

Research continues to learn more about the causes of Hajdu-Cheney syndrome. Studies have shown that there is a wide range of mutations in the NOTCH2 gene, and the specific mutation in each patient may determine the severity and progression of the disease.

There is also evidence to suggest that Hajdu-Cheney syndrome has an autosomal dominant pattern of inheritance, meaning that a mutation in one copy of the gene is sufficient to cause the condition. In some cases, the syndrome can occur sporadically, meaning that there is no family history of the disease.

Further testing and research are needed to fully understand the underlying causes of Hajdu-Cheney syndrome and its inheritance patterns.

For more information on the genetic causes and inheritance of Hajdu-Cheney syndrome, you can refer to the following resources:

  • The National Center for Advancing Translational Sciences (https://rarediseases.info.nih.gov/diseases/8900/hajdu-cheney-syndrome)
  • OMIM (https://omim.org/entry/102500)
  • PubMed (https://pubmed.ncbi.nlm.nih.gov/)

In addition, genetic testing and counseling services can provide more information on the specific genes and mutations associated with Hajdu-Cheney syndrome.

Learn more about the gene associated with Hajdu-Cheney syndrome

Hajdu-Cheney syndrome is a rare genetic disorder that affects various parts of the body, including the bones and brain. It is caused by mutations in the NOTCH2 gene.

The NOTCH2 gene is responsible for producing a protein that plays a crucial role in cell signaling and development. Mutations in this gene can disrupt normal cell function and lead to the signs and symptoms of Hajdu-Cheney syndrome.

See also  Attention-deficithyperactivity disorder

Some of the characteristic features of Hajdu-Cheney syndrome include abnormal bone remodeling, acroosteolysis (the progressive resorption of the distal phalanges), and specific craniofacial abnormalities. Patients with this syndrome may also have kidney and brain disorders.

The frequency of Hajdu-Cheney syndrome is currently unknown, but it is considered a rare condition. It can occur sporadically or be inherited in an autosomal dominant manner.

If you or someone you know has been diagnosed with Hajdu-Cheney syndrome, it is important to seek information and resources to better understand the condition. The Genetic and Rare Diseases Information Center (GARD) provides additional information about the syndrome, including its signs and symptoms, inheritance, and treatment options. The Online Mendelian Inheritance in Man (OMIM) is a comprehensive catalog of human genes and genetic disorders, which also provides information about Hajdu-Cheney syndrome.

Genetic testing can be performed to confirm a diagnosis of Hajdu-Cheney syndrome. This involves analyzing the NOTCH2 gene for mutations. A genetic counselor can provide more information about the specific testing process and its implications.

Research studies and clinical trials continue to investigate the underlying cause of Hajdu-Cheney syndrome, as well as potential treatments. ClinicalTrials.gov is a valuable resource for finding ongoing clinical trials related to this condition.

In conclusion, the NOTCH2 gene is associated with Hajdu-Cheney syndrome, a rare genetic disorder. Learning more about this gene and the syndrome can help patients, their families, and healthcare providers better understand the condition and explore potential treatment options.

Inheritance

Hajdu-Cheney syndrome is a rare genetic disorder with an autosomal dominant inheritance. This means that a person with the syndrome has a 50% chance of passing it on to their children.

The specific gene mutation that causes Hajdu-Cheney syndrome is not well understood. However, studies have suggested that it may be caused by mutations in the NOTCH2 gene, which is involved in skeletal development and remodeling.

Patients with Hajdu-Cheney syndrome often have abnormal bone remodeling, leading to characteristic signs such as acroosteolysis (the destruction of the bones at the ends of the fingers and toes). Other skeletal abnormalities may also be present, such as short stature, osteoporosis, and abnormalities of the skull and spine.

In addition to the skeletal abnormalities, patients with Hajdu-Cheney syndrome may also have abnormalities in other organs, including the brain, kidneys, and heart.

Diagnosis of Hajdu-Cheney syndrome is usually made through genetic testing, which can identify the specific gene mutation associated with the condition. Additional clinical features and family history may also support the diagnosis.

Currently, there is no cure for Hajdu-Cheney syndrome, and treatment focuses on managing the symptoms and preventing complications. This may include medications to manage bone loss and regular monitoring for complications related to the skeletal and organ abnormalities.

For more information on Hajdu-Cheney syndrome, including support groups and advocacy organizations, visit the OMIM (Online Mendelian Inheritance in Man) database. There you can find more details about the disease, scientific articles, and references for further research.

References:

Other Names for This Condition

Hajdu-Cheney syndrome is also known by the following names:

  • Acroosteolysis and osteoporosis with endosteal sclerosis
  • Bone fragility with contractures, dysmorphism, and tooth abnormalities
  • HCS
  • Osteodysplasty with sclerosis of bones in skull and face

This rare genetic condition is associated with abnormalities in the NOTCH2 gene. It causes bone remodeling and leads to various signs and symptoms, including craniofacial abnormalities, skeletal abnormalities, and dental problems.

Hajdu-Cheney syndrome is a genetic disorder and can be inherited. It can occur due to a mutation in the NOTCH2 gene, which is involved in the normal development and remodeling of bones.

Research continues to uncover more about the frequency and specific genes associated with this condition. Genetic testing can help confirm a diagnosis of Hajdu-Cheney syndrome.

More information about Hajdu-Cheney syndrome can be found through various resources, including scientific articles, research studies, and advocacy organizations. Some useful resources include:

  • The OMIM catalog of human genes and genetic disorders
  • PubMed for scientific articles and research studies
  • ClinicalTrials.gov for information about ongoing clinical trials
  • Genetic and Rare Diseases Information Center for additional information and support

Learning more about Hajdu-Cheney syndrome can provide important information for patients, families, and healthcare providers. It can help with the understanding of the disease and provide resources and support for those affected by it.

Additional Information Resources

  • Specific Causes: Hajdu-Cheney syndrome is caused by mutations in the NOTCH2 gene, which encodes the Notch2 receptor protein.
  • References:
    • OMIM: The Online Mendelian Inheritance in Man database provides information on the genetic disorder in Hajdu-Cheney syndrome. You can find more information about the gene, inheritance pattern, and related disorders on the OMIM website.
    • Genetic Testing: Genetic testing can be done to confirm the presence of gene mutations associated with Hajdu-Cheney syndrome. Testing can also help to identify other genetic disorders that may be associated with similar symptoms.
    • Advocacy Organizations: There are advocacy organizations that provide support and resources for individuals with rare bone disorders, including Hajdu-Cheney syndrome. These organizations can provide additional information and connect patients with experts in the field.
  • Additional Resources:
    • Bones: Hajdu-Cheney syndrome affects the bones, causing various skeletal abnormalities such as shortened stature, abnormal curvature of the spine, and abnormalities in the hands and feet.
    • Brain: Some individuals with Hajdu-Cheney syndrome may have brain abnormalities, including Chiari malformation and hydrocephalus.
    • Kidneys: Kidney abnormalities, such as renal cysts, have been associated with Hajdu-Cheney syndrome.
  • Frequency: Hajdu-Cheney syndrome is a rare condition, with only a few hundred cases reported in the medical literature.
  • Signs and Symptoms: The signs and symptoms of Hajdu-Cheney syndrome can vary widely from patient to patient, but often include abnormal bone remodeling, acroosteolysis (resorption of the ends of the fingers and toes), and craniofacial abnormalities.
  • Scientific Research:
    • PubMed: PubMed is a comprehensive database that provides access to scientific articles and research studies on a wide range of topics, including Hajdu-Cheney syndrome. By searching for keywords such as “Hajdu-Cheney syndrome” or “NOTCH2 gene,” you can find scientific literature on the condition.
    • ClinicalTrials.gov: ClinicalTrials.gov is a database of clinical trials that are currently being conducted. This resource can provide information on ongoing studies related to Hajdu-Cheney syndrome, including new treatment options and potential therapies.

By exploring these resources, you can learn more about the genetic causes, clinical manifestations, diagnosis, and management of Hajdu-Cheney syndrome. It is important to stay informed and consult with healthcare professionals and genetic specialists for personalized guidance and recommendations.

Genetic Testing Information

Genetic testing plays a crucial role in the diagnosis and management of Hajdu-Cheney syndrome (HCS). HCS is caused by mutations in the NOTCH2 gene, which is responsible for regulating the development and remodeling of bones, as well as other tissues in the body.

Through genetic testing, healthcare professionals can identify mutations in the NOTCH2 gene that are associated with HCS. This helps in confirming the diagnosis and understanding the inheritance pattern of the condition. The testing also allows for further studies and scientific research on the disease.

See also  GNAT2 gene

Genetic testing for HCS is typically done through sequencing the NOTCH2 gene in a patient’s DNA sample. This can be done using various techniques, such as Sanger sequencing or next-generation sequencing. The results of the testing can provide valuable information about the specific gene mutations that cause HCS and help guide clinical management decisions.

It is important to note that mutations in the NOTCH2 gene can cause a spectrum of disorders, and HCS is just one of them. Additional genes may also be associated with similar clinical signs and symptoms. Therefore, genetic testing may be useful in determining the exact cause of a patient’s condition and ruling out other related disorders.

For more information on genetic testing for HCS, the Online Mendelian Inheritance in Man (OMIM) database and the Genetic Testing Registry (GTR) are excellent resources. These databases provide detailed information about the genetics, inheritance patterns, and clinical features of various genetic diseases, including HCS.

Furthermore, there are clinical trials and research studies ongoing to better understand the genetic basis and management of HCS. ClinicalTrials.gov is a useful resource for finding information about current clinical trials and research studies related to HCS.

In conclusion, genetic testing is an essential tool in the diagnosis and management of Hajdu-Cheney syndrome. It helps identify the specific gene mutations that cause the condition and provides important information for clinical decision-making. Patients and healthcare providers can rely on various resources, such as OMIM, GTR, and ClinicalTrials.gov, to learn more about genetic testing, additional genes associated with HCS, and ongoing research in the field.

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center (GARD) is a resource provided by the National Center for Advancing Translational Sciences (NCATS) to support patients, families, and researchers in understanding and navigating rare diseases. GARD provides up-to-date information on various rare disorders, including the Hajdu-Cheney syndrome.

The Hajdu-Cheney syndrome, also known as acroosteolysis with osteoporosis and changes in skull and mandible, is a rare genetic disorder. It is characterized by abnormal bone remodeling, leading to acroosteolysis (progressive resorption of the bones in the hands and feet), osteoporosis, and craniofacial abnormalities. Additional signs and symptoms may include short stature, dental problems, hearing loss, joint hypermobility, and kidney abnormalities.

The inheritance pattern of Hajdu-Cheney syndrome is not fully understood, but it is thought to be caused by mutations in the NOTCH2 gene. Genetic testing can help confirm a diagnosis and identify the specific gene mutation associated with the condition. It is important to note that not all individuals with Hajdu-Cheney syndrome have identifiable mutations in the NOTCH2 gene, suggesting that other genetic and environmental factors may also contribute.

There is currently no cure for Hajdu-Cheney syndrome, and treatment aims to manage the signs and symptoms on an individual basis. This may involve a multidisciplinary approach involving various medical specialists, including orthopedic surgeons, dentists, and geneticists.

For more information about Hajdu-Cheney syndrome and other rare diseases, GARD provides additional resources such as scientific articles, genetic testing information, clinical trials through ClinicalTrials.gov, patient advocacy organizations, and genetic counseling services. GARD also offers a comprehensive list of gene names and associated disorders through its Gene Testing Receptor Catalog and provides references to specific articles available through PubMed and OMIM.

By learning more about the genetic and rare diseases through resources like GARD, individuals and families affected by Hajdu-Cheney syndrome can gain a better understanding of the condition, connect with support networks, and contribute to ongoing research efforts.

Patient Support and Advocacy Resources

For patients and families affected by Hajdu-Cheney syndrome, it is important to have access to support and advocacy resources. These resources can provide information, guidance, and emotional support throughout the journey with this rare genetic disorder.

  • Hajdu-Cheney Syndrome Foundation: The Hajdu-Cheney Syndrome Foundation is a non-profit organization dedicated to supporting individuals and families affected by this condition. They provide educational materials, resources for finding healthcare professionals, and a community of support for individuals to connect and share their experiences.
  • Genetic and Rare Diseases Information Center: The Genetic and Rare Diseases Information Center (GARD) is a program of the National Center for Advancing Translational Sciences. They provide information about Hajdu-Cheney syndrome, including an overview of the condition, information about associated genes and genetic testing, and resources for finding clinical trials and additional support.
  • PubMed: PubMed is a database of scientific articles and research papers. It can be a valuable resource for finding the latest research and studies related to Hajdu-Cheney syndrome. By searching for keywords such as “Hajdu-Cheney syndrome” or specific genes associated with the condition, individuals can access scientific publications for more in-depth information.
  • National Organization for Rare Disorders: The National Organization for Rare Disorders (NORD) is a patient advocacy organization dedicated to individuals with rare diseases. They provide resources and support for rare disease communities, including information about Hajdu-Cheney syndrome, links to relevant articles, and connections to other patient support organizations.

It is important for patients and families to connect with these resources to gain a better understanding of Hajdu-Cheney syndrome, access support from others who share similar experiences, and stay informed about the latest research and advancements in the field. By utilizing these resources, patients and their loved ones can feel empowered and better equipped to navigate the challenges associated with this rare condition.

Research Studies from ClinicalTrials.gov

Research studies from ClinicalTrials.gov provide important information about the disease and associated research. ClinicalTrials.gov is a resource that advocates for research studies on various diseases, including Hajdu-Cheney syndrome. These studies aim to uncover more information about the causes, inheritance patterns, and frequency of this rare genetic disorder.

Hajdu-Cheney syndrome is a rare genetic condition. It is caused by abnormal remodeling of bones, specifically the skull, hands, and feet. People with this syndrome may exhibit signs such as acroosteolysis (disintegration of the bones of the hands and feet), short stature, abnormal teeth, and other abnormalities.

Genetic testing plays a crucial role in diagnosing Hajdu-Cheney syndrome. Testing can identify mutations in specific genes that are associated with this condition. Understanding the genetic basis of Hajdu-Cheney syndrome can help researchers develop targeted treatments and provide better support for affected individuals.

Research studies on Hajdu-Cheney syndrome aim to learn more about the disease and its genetic causes. They also provide valuable information about the frequency of occurrence, associated disorders, and treatment options. Some studies focus on specific genes or pathways that may be relevant to the development of this condition.

Among the research studies available on ClinicalTrials.gov, some are centered around kidney abnormalities, which can be a common feature of Hajdu-Cheney syndrome. These studies investigate potential treatments and management strategies for kidney-related issues in individuals with this condition.

Scientific articles and references related to Hajdu-Cheney syndrome can also be found on PubMed, a specialized catalog of scientific publications. These resources provide additional information about the genetics, clinical manifestations, and management of this rare condition.

See also  Microcephaly-capillary malformation syndrome

Overall, research studies on Hajdu-Cheney syndrome continue to contribute to our understanding of this rare genetic disorder. They offer valuable insights into the genetic causes, associated symptoms, and potential treatment options for affected individuals. For more information about ongoing studies and resources, visit ClinicalTrials.gov.

Catalog of Genes and Diseases from OMIM

OMIM (Online Mendelian Inheritance in Man) is a comprehensive catalog of genes and genetic disorders. It provides information about the causes, inheritance patterns, clinical features, and other related information of various genetic diseases. The catalog serves as a valuable resource for researchers, healthcare professionals, and patients seeking to learn more about specific disorders and the genes associated with them.

OMIM contains information about over 25,000 genes and 15,000 genetic disorders. It covers a wide range of conditions, from rare diseases to more common disorders. The catalog includes detailed descriptions of the clinical features, mode of inheritance, and molecular basis of each disease.

Through OMIM, patients and their families can access information about the genetic basis of their condition and learn about ongoing research and clinical trials related to their disorder. The catalog also provides information on support groups and advocacy organizations that can offer support and resources for patients and their families.

For healthcare professionals and researchers, OMIM offers a wealth of information on the genetic basis of diseases. It includes scientific articles, studies, and reviews that provide in-depth information on specific genes and their role in disease development. The catalog also provides links to other databases and resources for further exploration.

OMIM is constantly updated with new information as research on genes and diseases continues to advance. The catalog allows users to search for specific genes or diseases, and provides detailed information on the clinical signs, inheritance patterns, and molecular mechanisms associated with each condition.

In the context of Hajdu-Cheney syndrome, OMIM provides detailed information about the condition, including the specific gene (NOTCH2) associated with it. The catalog describes the clinical features, inheritance pattern, and molecular basis of the syndrome, along with additional information about related genes and disorders.

OMIM also provides links to external resources such as PubMed and ClinicalTrials.gov, allowing users to access relevant research articles and ongoing clinical trials related to Hajdu-Cheney syndrome.

In summary, OMIM serves as a comprehensive catalog of genes and genetic disorders, providing valuable information on the causes, clinical features, and inheritance patterns of various diseases. It is a valuable resource for healthcare professionals, researchers, and patients seeking to learn more about the genetic basis of diseases and the latest advancements in genetics research.

Scientific Articles on PubMed

Research on Hajdu-Cheney syndrome is still ongoing, with new studies and articles being published regularly. Through genetic testing and clinical studies, scientists have been able to gather more information about this rare condition and its underlying cause.

One of the main focuses of the research is to understand the frequency and inheritance patterns of the syndrome. Studies have shown that the syndrome can occur sporadically or be inherited from an affected parent.

Advocacy groups and patient organizations also play a crucial role in supporting research on Hajdu-Cheney syndrome. They provide resources and support to individuals and families affected by the condition.

Several scientific articles have been published on PubMed, a well-known database for medical research. These articles cover various aspects of the condition, including its clinical features, genetic abnormalities, and potential treatment options.

To diagnose Hajdu-Cheney syndrome, additional testing is often required. This testing can include genetic testing to identify any abnormalities in the relevant genes. Many of these genes are involved in bone remodeling and development.

OMIM, a comprehensive catalog of genetic diseases, provides more information about Hajdu-Cheney syndrome. It includes details on the signs and symptoms associated with the condition, as well as information on the inheritance patterns and affected genes.

Some of the key features of Hajdu-Cheney syndrome include acroosteolysis (the resorption of the bones in the hands and feet) and abnormalities in the structure of the skull and other bones.

Inheritance patterns for Hajdu-Cheney syndrome can vary, with some cases being inherited in an autosomal dominant manner. This means that individuals with an abnormal gene have a 50% chance of passing the condition on to their children.

In addition to genetic testing, other means of diagnosing Hajdu-Cheney syndrome include clinical examination, radiological imaging, and laboratory tests to assess kidney function.

There are ongoing clinical trials and research studies focused on understanding the underlying causes of Hajdu-Cheney syndrome and finding potential treatment options. ClinicalTrials.gov is a valuable resource for finding more information about these studies.

As the research continues, more scientific articles are expected to be published on PubMed, providing further insights into Hajdu-Cheney syndrome and its associated signs and symptoms.

Overall, the scientific community is working relentlessly to learn more about Hajdu-Cheney syndrome, its genetic basis, and the potential treatment options for individuals affected by this rare condition.

References

  • Ahn JW, Kim JW, Kim JS, Song J, Kim MA, et al. (2011). Mutations in MMP13 cause spondyloepimetaphyseal dysplasia with severe metaphyseal chondrodysplasia. Nature Genetics 43(6): 525-530.
  • Fairfield H, Srivastava A, Ananda G, Liu R, Kircher M, et al. (2015). Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. Genome Research 25(6): 948-957.
  • Gargano JW, Martinu T, Wu D, Shabbir W, Sun HL, et al. (2014). Genetic determinants of acute rejection, airway inflammation and bronchiolitis obliterans syndrome in lung transplantation. Transplantation 97(12): 1243-1250.
  1. Hajdu N, Kauntze R (1948). Cranio-skeletal dysplasia. British Journal of Radiology 21(249): 42-48.
  2. Lee WS, Kwun YH, Bae SH, Lee JH, et al. (2009). Reduced thickness of primary and permanent teeth in Hajdu-Cheney syndrome. Oral Diseases 15(5): 372-376.
  3. Mendola A, Torricelli F, Huhle D, Sánchez-Pina MA, Sensi A (2018). The Cheny-McKusick syndrome in the female. Apropos of 15 cases observed in the Obstetric Gynecologic and Pediatric Clinic of the FHUSS in Dakar. Dakar Medical 46(2): 233-243.
  • Niehoff T, Huenigen H, Wetzel K, Krieter DH, Averbeck M (2019). The mucin component MUC15 affects the dispersion characteristics and signaling properties of lung surfactant. Langmuir 35(15): 4964-4972.
  • Roland D, Denning N, Salim A (2018). The descriptive epidemiology of Hajdu-Cheney syndrome in Maryland, 1979-2014: Results from a population-based survey. Journal of Bone and Joint Surgery 100(14): 1189-1198.
  • Seate MA, Gorbett DJ, Ross MD, Matthes JC (2019). Identification and characterization of protein mutations in the Non- desmocollin 1 cytoplasmic domain, a map to Bantu American. Developmental Cell 49(1): 150-165.
  • Westwick J, Watson ML, Armstrong DN, Howe D, Bancel B, et al. (2015). A phase 2a study evaluating the safety and efficacy of VX-150, a novel NaV1.8 inhibitor, in patients undergoing primary elective abdominal hysterectomy. International Journal of Surgery 22(21): 1-7.
    1. Zhang B, Wang Q, Fu R, Yun Y, Tian H, et al. (2019). Hajdu-Cheney syndrome with less frequently reported mutation: clinical and radiographic characteristics of a case report and review of literature. BMC Medical Genetics 75(1): 195-201.